TET2 somatic copy number alterations and allelic imbalances in chronic myelomonocytic leukemia

Vitamin C boosts DNA demethylation in TET2 germline mutation carriers

(2023) Aurora Taira et al.   Clinical Epigenetics

Single cell proteogenomic analysis of aberrant monocytosis in TET2 mutant premalignant and malignant hematopoiesis

(2023) Terra Lasho et al.   LEUKEMIA

Role of CBL Mutations in Cancer and Non-Malignant Phenotype

(2022) Davide Leardini et al.   Cancers

International Consensus Classification of Myeloid Neoplasms and Acute Leukemia: Integrating Morphological, Clinical, and Genomic Data

(2022) Daniel A. Arber et al.   BLOOD

High-resolution structural variant profiling of myelodysplastic syndromes by optical genome mapping uncovers cryptic aberrations of prognostic and therapeutic significance

(2022) Hui Yang et al.   LEUKEMIA

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

(2022) Joseph D. Khoury et al.   LEUKEMIA

A Single-Run Next-Generation Sequencing (NGS) Assay for the Simultaneous Detection of Both Gene Mutations and Large Chromosomal Abnormalities in Patients with Myelodysplastic Syndromes (MDS) and Related Myeloid Neoplasms

(2021) Alessandro Liquori et al.   Cancers

Mutant TET2 Allele Dosage Affects Response to 5-Azacitidine in Acute Myeloid Leukemia

(2020) Friedrich Stoelzel et al.   BLOOD

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

(2020) Elsa Bernard et al.   NATURE MEDICINE

EZH2 mutations and impact on clinical outcome - an analysis in 1604 patients with newly diagnosed acute myeloid leukemia

(2019) Sebastian Stasik et al.   HAEMATOLOGICA

Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)—a study of 1084 patients

(2019) Giacomo Coltro et al.   LEUKEMIA

Adverse prognostic effect of homozygous TET2 mutation on the relapse risk of acute myeloid leukemia in patients of normal karyotype

(2015) J.-S. Ahn et al.   HAEMATOLOGICA

Adverse prognostic effect of homozygous TET2 mutation on the relapse risk of acute myeloid leukemia in patients of normal karyotype

(2015) J.-S. Ahn et al.   HAEMATOLOGICA

Clonal architecture of chronic myelomonocytic leukemias

(2013) R. Itzykson et al.   BLOOD

Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies

(2011) Z. Li et al.   BLOOD

Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies

(2009) Jaroslaw P. Maciejewski et al.   BRITISH JOURNAL OF HAEMATOLOGY